These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 20460154)

  • 1. Cell-autonomous alteration of dopaminergic transmission by wild type and mutant (DeltaE) TorsinA in transgenic mice.
    Page ME; Bao L; Andre P; Pelta-Heller J; Sluzas E; Gonzalez-Alegre P; Bogush A; Khan LE; Iacovitti L; Rice ME; Ehrlich ME
    Neurobiol Dis; 2010 Sep; 39(3):318-26. PubMed ID: 20460154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Transgenic Mouse Model to Investigate the Cell-Autonomous Effects of torsinA(ΔE) Expression in Striatal Output Neurons.
    Gonzalez-Alegre P; Beauvais G; Martin J; Koch RJ; Walker RH; Patel JC; Rice ME; Ehrlich ME
    Neuroscience; 2019 Dec; 422():1-11. PubMed ID: 31669362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine release is impaired in a mouse model of DYT1 dystonia.
    Balcioglu A; Kim MO; Sharma N; Cha JH; Breakefield XO; Standaert DG
    J Neurochem; 2007 Aug; 102(3):783-8. PubMed ID: 17550429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function of dopamine transporter is compromised in DYT1 transgenic animal model in vivo.
    Hewett J; Johanson P; Sharma N; Standaert D; Balcioglu A
    J Neurochem; 2010 Apr; 113(1):228-35. PubMed ID: 20132487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine.
    Martella G; Tassone A; Sciamanna G; Platania P; Cuomo D; Viscomi MT; Bonsi P; Cacci E; Biagioni S; Usiello A; Bernardi G; Sharma N; Standaert DG; Pisani A
    Brain; 2009 Sep; 132(Pt 9):2336-49. PubMed ID: 19641103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-intrinsic effects of TorsinA(ΔE) disrupt dopamine release in a mouse model of TOR1A dystonia.
    Downs AM; Fan X; Kadakia RF; Donsante Y; Jinnah HA; Hess EJ
    Neurobiol Dis; 2021 Jul; 155():105369. PubMed ID: 33894367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased number of striatal cholinergic interneurons and motor deficits in dopamine receptor 2-expressing-cell-specific Dyt1 conditional knockout mice.
    Yokoi F; Oleas J; Xing H; Liu Y; Dexter KM; Misztal C; Gerard M; Efimenko I; Lynch P; Villanueva M; Alsina R; Krishnaswamy S; Vaillancourt DE; Li Y
    Neurobiol Dis; 2020 Feb; 134():104638. PubMed ID: 31618684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia.
    Dang MT; Yokoi F; McNaught KS; Jengelley TA; Jackson T; Li J; Li Y
    Exp Neurol; 2005 Dec; 196(2):452-63. PubMed ID: 16242683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptic vesicle recycling is enhanced by torsinA that harbors the DYT1 dystonia mutation.
    Kakazu Y; Koh JY; Ho KW; Gonzalez-Alegre P; Harata NC
    Synapse; 2012 May; 66(5):453-64. PubMed ID: 22213465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia.
    Song CH; Fan X; Exeter CJ; Hess EJ; Jinnah HA
    Neurobiol Dis; 2012 Oct; 48(1):66-78. PubMed ID: 22659308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia.
    Sciamanna G; Bonsi P; Tassone A; Cuomo D; Tscherter A; Viscomi MT; Martella G; Sharma N; Bernardi G; Standaert DG; Pisani A
    Neurobiol Dis; 2009 Apr; 34(1):133-45. PubMed ID: 19187797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tor1a+/- mice develop dystonia-like movements via a striatal dopaminergic dysregulation triggered by peripheral nerve injury.
    Ip CW; Isaias IU; Kusche-Tekin BB; Klein D; Groh J; O'Leary A; Knorr S; Higuchi T; Koprich JB; Brotchie JM; Toyka KV; Reif A; Volkmann J
    Acta Neuropathol Commun; 2016 Oct; 4(1):108. PubMed ID: 27716431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary: Dopaminergic dysfunction in DYT1 dystonia.
    Wichmann T
    Exp Neurol; 2008 Aug; 212(2):242-6. PubMed ID: 18513716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase-10A Inverse Changes in Striatopallidal and Striatoentopeduncular Pathways of a Transgenic Mouse Model of
    D'Angelo V; Castelli V; Giorgi M; Cardarelli S; Saverioni I; Palumbo F; Bonsi P; Pisani A; Giampà C; Sorge R; Biagioni S; Fusco FR; Sancesario G
    J Neurosci; 2017 Feb; 37(8):2112-2124. PubMed ID: 28115486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal dopaminergic dysregulation and dystonia-like movements induced by sensorimotor stress in a pharmacological mouse model of rapid-onset dystonia-parkinsonism.
    Rauschenberger L; Knorr S; Al-Zuraiqi Y; Tovote P; Volkmann J; Ip CW
    Exp Neurol; 2020 Jan; 323():113109. PubMed ID: 31712125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of human wildtype torsinA and human DeltaGAG torsinA in a transgenic mouse model causes phenotypic abnormalities.
    Grundmann K; Reischmann B; Vanhoutte G; Hübener J; Teismann P; Hauser TK; Bonin M; Wilbertz J; Horn S; Nguyen HP; Kuhn M; Chanarat S; Wolburg H; Van der Linden A; Riess O
    Neurobiol Dis; 2007 Aug; 27(2):190-206. PubMed ID: 17601741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia.
    Sciamanna G; Ponterio G; Tassone A; Maltese M; Madeo G; Martella G; Poli S; Schirinzi T; Bonsi P; Pisani A
    Neuropharmacology; 2014 Oct; 85():440-50. PubMed ID: 24951854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased dopamine receptor 1 activity and impaired motor-skill transfer in Dyt1 ΔGAG heterozygous knock-in mice.
    Yokoi F; Dang MT; Liu J; Gandre JR; Kwon K; Yuen R; Li Y
    Behav Brain Res; 2015 Feb; 279():202-10. PubMed ID: 25451552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic dysregulation produced by selective inactivation of the dystonia-associated protein torsinA.
    Sciamanna G; Hollis R; Ball C; Martella G; Tassone A; Marshall A; Parsons D; Li X; Yokoi F; Zhang L; Li Y; Pisani A; Standaert DG
    Neurobiol Dis; 2012 Sep; 47(3):416-27. PubMed ID: 22579992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal motor function and dopamine neurotransmission in DYT1 DeltaGAG transgenic mice.
    Zhao Y; DeCuypere M; LeDoux MS
    Exp Neurol; 2008 Apr; 210(2):719-30. PubMed ID: 18299128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.